Form D — Bobo Labs Inc
0002055372-25-000002 · filed 2025-02-11
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $6,000,000
- Total sold
- $250,000
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bobo Labs Inc
- CIK
- 2055372
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 913 N Pennsylvania Av
Yardlsley, PA 10967 - Phone
- (212) 907-7370
Related persons
-
Edouard Fernand LeMarie · DirectorPennedepie, I0
-
Benedicte LeMarie · DirectorPennedepie, I0
-
Kethleen Widmer · Executive OfficerYardlsley, PA
-
Walid Abboud · DirectorLondon, X0
-
Lawrence Bell · DirectorNew York, NY
-
Felipe Jimenez · DirectorRialto, CA
-
Ludmilla Le Marie · DirectorNassau, C5
-
Michael McNamara · DirectorPalos Verdes Estates, CA
-
Turner Novak · DirectorAnn Arbor, MI
-
Barry Bruno · Executive OfficerPrinceton, NJ
View original on SEC EDGAR.